Home › Funds › Atle Fund Management AB › BIIB

Atle Fund Management AB position in BIIB

BIOGEN INC · Health Care

Atle Fund Management AB reported holding 70,955 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$16.0M, representing 4.29% of its reported portfolio and ranking #6 among its reported holdings. Atle Fund Management AB has disclosed BIIB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)70.95K sh
Reported value held$16.03M
Portfolio Weight4.29%
First reportedQ2 2026
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's BIIB position evolved

Atle Fund Management AB first disclosed a stake in BIIB in Q2 2026 at 62,781 shares (US$13.6M). The position peaked in Q3 2026 at 70,955 shares, worth US$16.0M. Across 2 filings, Atle Fund Management AB increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 70,955 shares valued at US$16.0M — an increase of 8,174 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 62.78K $13.56M New
Q3 2026 70.95K $16.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 21 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has Atle Fund Management AB held BIIB?

Atle Fund Management AB has disclosed BIIB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Atle Fund Management AB's current position in BIIB?

As of Q3 2026, Atle Fund Management AB holds 70.95K shares of BIIB (BIOGEN INC), valued at $16.03M, representing 4.29% of its reported portfolio and ranking #6.

Has Atle Fund Management AB been buying or selling BIIB?

In the latest 13F filing (Q3 2026), Atle Fund Management AB increased its position in BIIB. The position peaked in Q3 2026 at 70.95K shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.